Transformant having improved productivity of 4-hydroxybenzoic acid

By suppressing or deleting pyruvate kinase and phosphoenolpyruvate carboxylase functions in Corynebacterium bacteria, 4-hydroxybenzoic acid production is enhanced, addressing the inefficiencies in existing methods and reducing environmental impact.

WO2026235171A1PCT designated stage Publication Date: 2026-11-12KAO CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/017515
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-05-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing methods for producing 4-hydroxybenzoic acid using Corynebacterium bacteria do not effectively enhance productivity, despite attempts to disrupt the pyruvate kinase gene, and there is a need for a more efficient, environmentally friendly production method.

Method used

Suppress or delete the functions of polypeptides with pyruvate kinase and phosphoenolpyruvate carboxylase activities in Corynebacterium bacteria to enhance 4-hydroxybenzoic acid production.

Benefits of technology

Significantly improves 4-hydroxybenzoic acid production in Corynebacterium bacteria, enabling efficient fermentation with a lower environmental impact.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JPOXMLDOC01-APPB-C000001
    Figure JPOXMLDOC01-APPB-C000001
  • Figure JPOXMLDOC01-APPB-C000002
    Figure JPOXMLDOC01-APPB-C000002
  • Figure JPOXMLDOC01-APPB-C000003
    Figure JPOXMLDOC01-APPB-C000003
Patent Text Reader

Abstract

Provided are: a transformant of a bacterium of the genus Corynebacterium, the transformant having improved productivity of 4-hydroxybenzoic acid; and a method for using the same. The present invention provides a transformant of a bacterium of the genus Corynebacterium capable of producing 4-hydroxybenzoic acid, wherein the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively.
Need to check novelty before this filing date? Find Prior Art

Description

4-hydroxybenzoic acid productivity-enhanced transformant

[0001] This invention relates to a transformed bacterium of the genus Corynebacterium with improved productivity of 4-hydroxybenzoic acid, and its use.

[0002] 4-Hydroxybenzoic acid (4-HBA) is used not only as a monomer for liquid crystal polymers, but also has a wide range of applications as an antioxidant and a raw material for pesticides. 4-HBA is produced by the Kolbe-Schmidt reaction, which involves reacting petroleum-derived phenol alkali salts with carbon dioxide at high temperature and pressure. However, from the perspective of reducing greenhouse gas (GHG) emissions, the shift to bio-based raw materials is becoming a challenge.

[0003] In recent years, there has been a growing demand for the production of useful aromatic compounds from glucose, an inexpensive raw material, using microorganisms. Among these, Corynebacterium glutamicum is a useful industrial microorganism that has been used for the production of various amino acids and nucleic acids. In recent years, with the establishment of genetic engineering technology targeting Corynebacterium glutamicum, it has become possible to produce a variety of organic compounds, including aromatic compounds such as 4-HBA (Non-Patent Literature 1).

[0004] On the other hand, in relation to 4-HBA production in Corynebacteria, attempts were made to disrupt the gene encoding pyruvate kinase, which is involved in the metabolism of phosphoenolpyruvate (PEP), a metabolite located upstream in the 4-HBA biosynthesis pathway, in order to increase the amount of PEP. However, it has been reported that 4-HBA production did not improve (Non-Patent Literature 2).

[0005] (Non-patent document 1) Judith Becker et al. Metab. Eng. 2018. 50:122-141. (Non-patent document 2) Henry Syukur Purwanto et al. J. Biotechnol. 2018. 282:92-100.

[0006] The present invention relates to the following 1) to 4): 1) A transformed bacterium of the genus Corynebacterium having the ability to produce 4-hydroxybenzoic acid, wherein the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively. 2) A method for producing 4-hydroxybenzoic acid or a salt thereof, comprising the step of culturing the transformed bacterium described in 1). 3) A method for producing a transformed bacterium of the genus Corynebacterium having the ability to produce 4-hydroxybenzoic acid, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively. 4) A method for improving the productivity of 4-hydroxybenzoic acid in a bacterium of the genus Corynebacterium having the ability to produce 4-hydroxybenzoic acid, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively.

[0007] A schematic diagram showing the 4-hydroxybenzoic acid (4-hydroxybenzoic acid) production pathway in Corynebacterium glutamicum, which has the ability to produce 4-hydroxybenzoic acid. In the diagram, aroG and aroF are genes encoding 2-dehydro-3-deoxyarabinoheptonate aldolase, aroB is a gene encoding 3-dehydroquinate synthase, aroD is a gene encoding dehydroquinate dehydratase, aroE3 is shikimate dehydrogenase, aroK is a gene encoding shikimate kinase, aroA is a gene encoding 5-enolate pyruvyl shikimate-3-phosphate synthase, and aroC is a gene encoding colismyate synthase. These are endogenous genes of Corynebacterium glutamicum. ubiC is a gene encoding colismyate lyase, and this is a pathway metabolized by external gene introduction. In the diagram, PEP is phosphoenolpyruvic acid, DAHP is 3-deoxy-D-arabino-heptulosonic acid 7-phosphate, DHQ is dehydroquinic acid, DHS is dehydroshikimic acid, SHK is shikimic acid, S3P is shikimic acid-3-phosphate, EPSP is 5-enoylpyruvinylic shikimic acid-3-phosphate, CHA is colismic acid, and 4HBA is 4-hydroxybenzoic acid. Detailed description of the invention

[0008] In this specification, the identity of amino acid sequences or nucleotide sequences is calculated by the Lipman-Pearson method (Science, 1985, 227:1435-1441). Specifically, it is calculated by performing the homology analysis (Search homology) using the genetic information processing software GENETYX Ver. 12, with the Unit size to compare (ktup) set to 2.

[0009] In this specification, "at least 90% identity" with respect to an amino acid sequence or nucleotide sequence means identity of 90% or more, preferably 95% or more, more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more. In this specification, "at least 80% identity" with respect to an amino acid sequence or nucleotide sequence means identity of 80% or more, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, still more preferably 97% or more, still more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more.

[0010] In this specification, "amino acid sequence in which one or more amino acids are deleted, substituted, added, or inserted" means an amino acid sequence in which one to 95, preferably one to 72, more preferably one to 48, even more preferably one to 24, even more preferably one to 19, even more preferably one to 14, even more preferably one to 10, even more preferably one to 5, and even more preferably one to 2 amino acids are deleted, substituted, added, or inserted. Furthermore, "a nucleotide sequence in which one or more nucleotides are deleted, substituted, added, or inserted" refers to a nucleotide sequence in which one to 287, preferably one to 215, more preferably one to 144, even more preferably one to 72, even more preferably one to 57, even more preferably one to 42, even more preferably one to 30, even more preferably one to 15, and even more preferably one to 6 nucleotides are deleted, substituted, added, or inserted. In the present invention, "addition" of an amino acid or nucleotide includes the addition of an amino acid or nucleotide to one end and both ends of a sequence. In the present invention, "deletion" of an amino acid or nucleotide includes the deletion of an amino acid or nucleotide at one end and both ends of a sequence, but it is preferable that the deletion is of an amino acid or nucleotide inside the sequence. Furthermore, in the present invention, deletion, substitution, addition, or insertion of an amino acid or nucleotide is preferred, and deletion, substitution, or insertion of an amino acid or nucleotide inside the sequence is more preferred.

[0011] In this specification, "operable linkage" between a regulatory region and a gene means that the gene and the regulatory region are linked in such a way that the gene can be expressed under the control of the regulatory region. Procedures for "operable linkage" between a gene and a regulatory region are well known to those skilled in the art.

[0012] In this specification, "upstream" and "downstream" with respect to a gene refer to the upstream and downstream regions in the transcription direction of the gene. For example, "a gene located downstream of a promoter" means that the gene is located on the 3' side of the promoter in the DNA sense strand, and the upstream of a gene means the 5' region of the gene in the DNA sense strand.

[0013] In this specification, the term "inherent" used with respect to the function, characteristics, or traits of a cell is used to indicate that such function, characteristic, or trait is present in the wild type of the cell. In contrast, the term "external" is used to indicate a function, characteristic, or trait that is not originally present in the cell but has been introduced from outside. For example, an "external" gene or polynucleotide is a gene or polynucleotide that has been introduced into a cell from outside. An external gene or polynucleotide may originate from the same species of organism as the cell into which it was introduced, or from a different species of organism (i.e., a heterologous gene or polynucleotide).

[0014] The present invention relates to a transformed bacterium of the genus Corynebacterium with improved productivity of 4-hydroxybenzoic acid, and a method for producing 4-hydroxybenzoic acid compounds or salts thereof using the same.

[0015] The inventors have found that in Corynebacterium bacteria capable of producing 4-hydroxybenzoic acid, the productivity of 4-hydroxybenzoic acid is improved by suppressing or deleting the function of a polypeptide having pyruvate kinase activity and a polypeptide having phosphoenolpyruvate carboxylase activity, respectively.

[0016] According to the present invention, it becomes possible to efficiently produce 4-hydroxybenzoic acids or their salts by a fermentation method that has a low environmental impact.

[0017] As shown in the examples described later, in Corynebacterium bacteria capable of producing 4-hydroxybenzoic acid, deleting only one of the polypeptide functions—either the polypeptide with pyruvate kinase activity or the polypeptide with phosphoenolpyruvate carboxylase activity—resulted in 4-hydroxybenzoic acid production being equivalent to that of parent bacteria where both polypeptide functions were not suppressed or deleted. However, surprisingly, deleting both polypeptide functions resulted in a significant improvement in 4-hydroxybenzoic acid production compared to parent bacteria. Therefore, transformants of Corynebacterium bacteria capable of producing 4-hydroxybenzoic acid in which the polypeptide functions with pyruvate kinase activity and the polypeptide functions with phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively, exhibit significantly improved 4-hydroxybenzoic acid production compared to parent bacteria and are useful for the production of 4-hydroxybenzoic acid compounds or their salts.

[0018] The Corynebacterium transformant of the present invention is a Corynebacterium transformant having the ability to produce 4-hydroxybenzoic acid, in which the function of the polypeptide having pyruvate kinase activity and the function of the polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively.

[0019] In the present invention, the polypeptide (A) having pyruvate kinase activity is preferably the polypeptide (A1) or (A2) described below. (A1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 35. (A2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35. Here, (A1) the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 35 refers to pyruvate kinase derived from Corynebacterium glutamicum. Pyruvate kinase (EC2.7.1.40) is an enzyme that transfers a phosphate group from phosphoenolpyruvate to ADP, producing pyruvate and ATP.

[0020] In the polypeptide of (A2), the identity with the amino acid sequence shown in SEQ ID NO: 35 is 90% or more, preferably 95% or more, more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more. An example of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35 is an amino acid sequence in which one or more amino acids are deleted, substituted, added, or inserted from the amino acid sequence shown in SEQ ID NO: 35.

[0021] The polypeptide of (A2) is preferably a polypeptide having pyruvate kinase activity. The presence of pyruvate kinase activity of a polypeptide can be confirmed, for example, by adding the polypeptide to a solution containing phosphoenolpyruvate, ADP, magnesium chloride, lactate dehydrogenase, and NADH, and measuring the decrease in NADH by absorbance.

[0022] Polypeptides consisting of amino acid sequences having at least 90% identity with the amino acid sequence shown in Sequence ID No. 35 of (A2) include, for example, pyruvate kinase derived from Corynebacterium glutamicum R strain (Sequence ID No. 49), pyruvate kinase derived from Corynebacterium efficiens NBRC100395 strain (Sequence ID No. 50), pyruvate kinase derived from Corynebacterium crudilactis (Sequence ID No. 52), pyruvate kinase derived from Corynebacterium suranareeae (Sequence ID No. 54), and pyruvate kinase derived from Corynebacterium callunae (Sequence ID No. 55).

[0023] Furthermore, in the present invention, the polypeptide (B) having phosphoenolpyruvate carboxylase activity is preferably the polypeptide (B1) or (B2) described below. (B1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 37. (B2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37. Here, (B1) the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 37 refers to phosphoenolpyruvate carboxylase derived from Corynebacterium glutamicum. Phosphoenolpyruvate carboxylase (EC 4.1.1.31) is an enzyme that converts phosphoenolpyruvate and bicarbonate ions into oxaloacetate.

[0024] In polypeptide (B2), the identity with the amino acid sequence shown in SEQ ID NO: 37 is 90% or more, preferably 95% or more, more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more. An example of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 is an amino acid sequence in which one or more amino acids are deleted, substituted, added, or inserted from the amino acid sequence shown in SEQ ID NO: 37.

[0025] The polypeptide of (B2) is preferably a polypeptide having phosphoenolpyruvate carboxylase activity. The presence of phosphoenolpyruvate carboxylase activity in a polypeptide can be confirmed, for example, by adding the polypeptide to a solution containing phosphoenolpyruvate, sodium bicarbonate, magnesium chloride, malate dehydrogenase, and NADH, and measuring the decrease in NADH by absorbance.

[0026] Polypeptides having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 of (B2) include, for example, phosphoenolpyruvate carboxylase from Corynebacterium glutamicum R strain (SEQ ID NO: 57), phosphoenolpyruvate carboxylase from Corynebacterium crudilactis (SEQ ID NO: 59), and phosphoenolpyruvate carboxylase from Corynebacterium suranareeae (SEQ ID NO: 61).

[0027] Methods for introducing mutations such as deletion, substitution, addition, or insertion of amino acids into the amino acid sequence of the polypeptide mentioned above include, for example, introducing mutations such as deletion, substitution, addition, or insertion of nucleotides into the nucleotide sequence encoding the amino acid sequence. Methods for introducing mutations into nucleotide sequences include, for example, mutagenesis using chemical mutagens such as ethyl methanesulfonate, N-methyl-N-nitrosoguanidine, and nitrite, or physical mutagens such as ultraviolet light, X-rays, gamma rays, and ion beams; site-directed mutagenesis; the method described by Dieffenbach et al. (Cold Spring Harbor Laboratory Press, New York, 581-621, 1995); and genome editing using artificial DNA nuclease (artificial DNA nuclease or programmeable nuclease). Site-directed mutagenesis methods include Splicing overlap extension (SOE) PCR (Horton et al., Gene 77, 61-68, 1989), ODA method (Hashimoto-Gotoh et al., Gene, 152, 271-276, 1995), and Kunkel method (Kunkel, T.A., Proc. Natl. Acad. Sci. USA, 1985, 82, 488). Alternatively, there are methods such as Site-Directed Mutagenesis System Mutan-SuperExpress Km kit (Takara Bio Inc.) and Transformer.TM Commercially available site-directed mutagenesis kits, such as the Site-Directed Mutagenesis Kit (Clontech) and the KOD-Plus-Mutagenesis Kit (Toyobo), can also be used.

[0028] In the present invention, transformants of Corynebacterium bacteria in which the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively, include bacterial strains in which the expression of a polypeptide having pyruvate kinase activity in the host bacterium is reduced or lost, and the function of said polypeptide as pyruvate kinase is suppressed or deleted, and the expression of a polypeptide having phosphoenolpyruvate carboxylase activity in the host bacterium is reduced or lost, and the function of said polypeptide as phosphoenolpyruvate carboxylase is suppressed or deleted. Preferably, bacterial strains (mutagenic strains) in which the expression of a polypeptide having pyruvate kinase activity is reduced or lost compared to the parent bacterium by introducing a mutation, and the function of said polypeptide as pyruvate kinase is reduced or deleted, and the expression of a polypeptide having phosphoenolpyruvate carboxylase activity is reduced or deleted compared to the parent bacterium by introducing a mutation, and the function of said polypeptide as phosphoenolpyruvate carboxylase is reduced or deleted. In the present invention, "expression" of a polypeptide means that a translation product is produced from the gene encoding the polypeptide and is localized to its site of action in a functional state. A decrease or loss of polypeptide expression includes not only a decrease or loss of expression of the functional polypeptide itself with its original activity, but also a decrease or loss of expression of the functional polypeptide with its original activity due to activity suppression, and activity suppression may be either complete suppression (inhibition) or incomplete suppression. A decrease or loss of expression of a polypeptide having pyruvate kinase activity and a polypeptide having phosphoenolpyruvate carboxylase activity, respectively, due to the introduction of a mutation means a state in which, as a result of modification at the gene level, transcription level, post-transcriptional regulation level, translation level, or post-translational modification level, the amount of polypeptide having pyruvate kinase activity and the amount of polypeptide having phosphoenolpyruvate carboxylase activity present in the transformant is reduced or lost, preferably a state in which they are significantly reduced or lost compared to those in the parent bacterium.

[0029] "Decreased expression of polypeptide having pyruvate kinase activity compared to parent bacteria" means that the expression level of polypeptide having pyruvate kinase activity present in the transformant is lower than that of parent bacteria. More specifically, compared to parent bacteria, the expression level of the protein is usually 50% or less, preferably 20% or less, more preferably 10% or less, and as a result, its activity is also similarly reduced. Even more preferably, the expression level of polypeptide having pyruvate kinase activity is 0%, i.e., loss of expression of polypeptide having pyruvate kinase activity. "Decreased expression of polypeptide having phosphoenolpyruvate carboxylase activity compared to parent bacteria" means that the expression level of polypeptide having phosphoenolpyruvate carboxylase activity present in the transformant is lower than that of parent bacteria. More specifically, compared to parent bacteria, the expression level of the protein is usually 50% or less, preferably 20% or less, more preferably 10% or less, and as a result, its activity is also similarly reduced. Even more preferably, the expression level of polypeptide having phosphoenolpyruvate carboxylase activity is 0%, i.e., loss of expression of polypeptide having phosphoenolpyruvate carboxylase activity. Furthermore, comparisons of the expression levels of polypeptides possessing pyruvate kinase activity and polypeptides possessing phosphoenolpyruvate carboxylase activity are performed by measuring enzyme activity, etc. Alternatively, the expression levels of these polypeptides can be measured using well-known immunological methods such as Western blotting and immunohistochemistry.

[0030] Transformed organisms in which the expression of the polypeptide having pyruvate kinase activity and the polypeptide having phosphoenolpyruvate carboxylase activity are reduced or lost can be obtained, specifically, by suppressing the function of the gene encoding the polypeptide having pyruvate kinase activity and the gene encoding the polypeptide having phosphoenolpyruvate carboxylase activity on the chromosomal DNA of the host bacterium. Here, suppression of gene function includes not only suppression of gene expression but also suppression of the activity of the polypeptide encoded by the gene, and the suppression of function may be either complete suppression (inhibition) or incomplete suppression.

[0031] A gene encoding a polypeptide having pyruvate kinase activity means DNA consisting of a transcription region including an ORF and a transcriptional regulatory region such as the promoter of the gene. In the present invention, the following polynucleotides (a1) or (a2) are preferred as genes encoding the polypeptide of (A1) or (A2). (a1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 34 (a2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 34; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35. As for the polynucleotide of (a2), a polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 34 is preferred. Here, (a1) the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 34 refers to the pyk gene (cg2291) encoding pyruvate kinase from Corynebacterium glutamicum. (a2) The polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 48 refers to the gene encoding pyruvate kinase from Corynebacterium glutamicum strain R, the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 51 refers to the gene encoding pyruvate kinase from Corynebacterium cludilactis, and the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 53 refers to the gene encoding pyruvate kinase from Corynebacterium stranareae. Preferably, the polynucleotide in (a2) is a polynucleotide encoding a polypeptide having pyruvate kinase activity.

[0032] A gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity means DNA consisting of a transcription region containing ORF and a transcriptional regulatory region such as the promoter of the gene. In the present invention, the genes encoding the polypeptide of (B1) or (B2) above preferably include the following polynucleotides (b1) or (b2): (b1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 36 (b2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 36; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37. As for the polynucleotide of (b2), a polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 36 is preferred. Here, (b1) the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 36 refers to the ppc gene (cg1787) from Corynebacterium glutamicum that encodes phosphoenolpyruvate carboxylase. (b2) The polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 56 refers to the gene encoding phosphoenolpyruvate carboxylase from Corynebacterium glutamicum strain R, the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 58 refers to the gene encoding phosphoenolpyruvate carboxylase from Corynebacterium cludilactis, and the polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 60 refers to the gene encoding phosphoenolpyruvate carboxylase from Corynebacterium stranareae. Preferably, the polynucleotide in (b2) is a polynucleotide encoding a polypeptide having phosphoenolpyruvate carboxylase activity.

[0033] In the polynucleotide of (a2) or (b2), the identity with the nucleotide sequence shown by SEQ ID NOs: 34, 48, 51, 53, 36, 56, 58, or 60 is 90% or more, preferably 95% or more, more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more, and even more preferably 99.5% or more. An example of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown by SEQ ID NOs: 34, 48, 51, 53, 36, 56, 58, or 60 is a nucleotide sequence in which one or more nucleotides are deleted, substituted, added, or inserted from the nucleotide sequence shown by SEQ ID NOs: 34, 48, 51, 53, 36, 56, 58, or 60. The method for introducing mutations such as nucleotide deletion, substitution, addition, or insertion into a nucleotide sequence is as described above.

[0034] The function of a gene encoding a polypeptide having pyruvate kinase activity can be suppressed by introducing a deletion or inactivation mutation into the coding region, non-coding region, transcriptional regulatory region, transcription initiation region, and / or translation initiation region of the gene encoding the polypeptide having pyruvate kinase activity (deletion or inactivation of the gene encoding the polypeptide having pyruvate kinase activity), or by introducing a polynucleotide that has the activity to degrade the transcript of the gene encoding the polypeptide having pyruvate kinase activity, or a polynucleotide that suppresses the translation of the transcript into protein. Furthermore, the transcription of the target gene can be suppressed by using a Cas protein lacking nuclease activity and a guide nucleic acid that binds to the promoter region or near the transcription initiation of the target gene.

[0035] In one embodiment, deletion or inactivation of a gene encoding a polypeptide having pyruvate kinase activity can be achieved by removing or replacing part or all of the nucleotide sequence of the coding region, non-coding region, transcriptional regulatory region, transcription initiation region and / or translation initiation region of the gene encoding the polypeptide having pyruvate kinase activity from the genome or by replacing it with another nucleotide sequence; inserting another polynucleotide fragment into the nucleotide sequence of the coding region, non-coding region, transcriptional regulatory region, transcription initiation region and / or translation initiation region of the gene encoding the polypeptide having pyruvate kinase activity; or by introducing a mutation into the nucleotide sequence of the coding region, non-coding region, transcriptional regulatory region, transcription initiation region and / or translation initiation region of the gene encoding the polypeptide having pyruvate kinase activity. Preferably, part or all of the nucleotide sequence of the coding region, non-coding region, transcriptional regulatory region, transcription initiation region and / or translation initiation region of the gene encoding the polypeptide having pyruvate kinase activity is deleted or inactivated. More specific examples include a method for specifically deleting or inactivating the nucleotide sequence of a gene encoding a polypeptide having pyruvate kinase activity on the genome of a cell, specifically the coding region, non-coding region, transcriptional regulatory region (e.g., promoter region), transcription initiation region and / or translation initiation region, preferably the coding region and / or transcriptional regulatory region, more preferably the coding region; and a method for selecting cells with the desired mutation by randomly deleting or inactivating mutations in the nucleotide sequence of the coding region, non-coding region, transcriptional regulatory region, transcription initiation region and / or translation initiation region, preferably the coding region and / or transcriptional regulatory region, more preferably the coding region of the gene in bacterial cells, and then evaluating the expression level and activity of the polypeptide having pyruvate kinase activity, or performing genetic analysis. In one preferred example, the nucleotide sequence of the coding region of a gene encoding a polypeptide having pyruvate kinase activity is specifically deleted. In another preferred example, an inactivating mutation is introduced into the nucleotide sequence of the coding region of a gene encoding a polypeptide having pyruvate kinase activity.In another preferred example, an inactivating mutation is introduced into the nucleotide sequence of the transcription factor binding motif of the gene encoding a polypeptide having pyruvate kinase activity. In another preferred example, the nucleotide sequence of the promoter region of the gene encoding a polypeptide having pyruvate kinase activity is replaced with the nucleotide sequence of a low-expression promoter.

[0036] Specific deletion or inactivation of genes encoding polypeptides with pyruvate kinase activity can be achieved, for example, by homologous recombination. Specifically, a DNA fragment of a gene encoding a polypeptide with pyruvate kinase activity can be constructed by introducing an inactivating mutation through polynucleotide substitution or insertion, or by constructing a DNA fragment that includes the outer region of a gene encoding a polypeptide with pyruvate kinase activity but does not include the gene itself. This fragment can then be incorporated into the parent bacterium to induce homologous recombination with the region of the parent bacterium's genome containing the gene encoding the polypeptide with pyruvate kinase activity, thereby deleting or inactivating the gene encoding the polypeptide in the genome. Alternatively, a recombinant vector (such as a plasmid) containing a DNA fragment with a portion of the region of the gene encoding the polypeptide with pyruvate kinase activity can be incorporated into the parent bacterium, and the gene encoding the polypeptide can be inactivated by homologous recombination by disrupting that region of the parent bacterium's genome. Methods for randomly deleting or inactivating genes in bacterial cells include introducing randomly cloned DNA fragments containing inactivating mutations into cells and inducing homologous recombination with genes on the cell's genome, and inducing mutations by irradiating cells with ultraviolet light, gamma rays, etc. Inactivating mutations in genes refer to mutations such as missense mutations, nonsense mutations, and frameshift mutations that impair the function of the target gene. For example, a gene into which an inactivating mutation has been introduced will either not express a polypeptide or will express a polypeptide with impaired original activity.For gene inactivation mutations, tools such as AlphaFold2 (Nature, 2021, 596: p583-589) and SWISS-MODEL (Nucleic Acids Research, 2018, 46: W296-W303) can be used to predict the three-dimensional structure of the polypeptide encoded by the gene. Based on the predicted structure, functionally important regions of the polypeptide can be identified, and the mutation site can be determined by targeting the amino acid sequence of that region and, consequently, the nucleotide sequence encoding that region. Furthermore, the functionally important regions of the polypeptide can be predicted by bioinformatics analysis known to those skilled in the art. For example, by analyzing the amino acid sequence of the target polypeptide using tools such as InterPro, which integrates information on protein families, domains, and functional sites; Pfam, which classifies protein sequences into families and domains; CDD, which provides annotations for conserved domains and conserved functional sites; and SMART, for protein domain identification and domain architecture analysis, the functional regions, conserved motifs, and functionally important residues contained in the target polypeptide can be predicted.

[0037] One method for constructing a DNA fragment containing a gene encoding a polypeptide with pyruvate kinase activity into which an inactivating mutation has been introduced is site-directed mutagenesis (SMU). Site-directed mutagenesis can be performed using mutation primers containing the nucleotide mutation to be introduced. For example, by PCR using a gene encoding a polypeptide with pyruvate kinase activity as a template with two sets of primers containing the nucleotide mutation to be introduced, DNA fragments can be prepared by amplifying the upstream and downstream regions of the region containing the gene encoding the polypeptide with pyruvate kinase activity, respectively. These fragments can then be ligated together by SOE-PCR (splicing by overlap extension PCR) (Gene, 1989, 77(1): p61-68) to construct a DNA fragment containing the desired mutation. Alternatively, site-directed mutagenesis can be performed using methods such as inverse PCR or annealing (Muramatsu et al., "Revised 4th Edition New Genetic Engineering Handbook," Yodosha, pp. 82-88), genome editing using artificial DNA cutting enzymes, or commercially available site-directed mutagenesis kits such as Stratagene's QuickChange II Site-Directed Mutagenesis Kit or QuickChange Multi Site-Directed Mutagenesis Kit.

[0038] Mutation primers can be prepared by well-known oligonucleotide synthesis methods such as the phosphoramidite method (Nucleic Acids Research, 1989, 17:7059-7071). The gene encoding a polypeptide with pyruvate kinase activity to be used as a template may be prepared from host bacteria by conventional methods or chemically synthesized.

[0039] For introducing DNA fragments or vectors into host bacteria, well-known techniques such as the calcium phosphate method, electroporation method, lipofection method, particle gun method, PEG method and the like can be applied. Examples of methods applicable to coryneform bacteria include the competent cell transformation method (J Bacteriol, 1967, 93: 1925-1937), electroporation method (FEMS Microbiol Lett, 1990, 55: 135-138), protoplast transformation method (Mol Gen Genet, 1979, 168: 111-115), Tris-PEG method (J Bacteriol, 1983, 156: 1130-1134) and the like.

[0040] Further, examples of the polynucleotide having an activity of degrading the transcription product of a gene encoding a polypeptide having pyruvate kinase activity, or the polynucleotide that suppresses translation of the transcription product into the polypeptide, include a polynucleotide comprising a nucleotide sequence complementary or substantially complementary to the nucleotide sequence of the mRNA of the gene encoding the polypeptide having pyruvate kinase activity, or a part thereof. Specific examples include antisense RNA against the mRNA of the gene encoding the polypeptide having pyruvate kinase activity, siRNA against the mRNA of the gene encoding the polypeptide having pyruvate kinase activity, ribozyme against the mRNA of the gene encoding the polypeptide having pyruvate kinase activity, and the like.

[0041] Bacteria in which the function of the gene encoding the polypeptide having pyruvate kinase activity is suppressed can be selected by confirming their genome sequences. Alternatively, bacteria in which the function of the gene encoding the polypeptide having pyruvate kinase activity is suppressed can be selected using the expression level or activity of the polypeptide having pyruvate kinase activity as an indicator.

[0042] The function of a gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity can be suppressed by introducing a deletion or inactivation mutation into the coding region, non-coding region, transcriptional regulatory region, transcription initiation region, and / or translation initiation region of the gene encoding the polypeptide having phosphoenolpyruvate carboxylase activity (deletion or inactivation of the gene encoding the polypeptide having phosphoenolpyruvate carboxylase activity), or by introducing a polynucleotide that has the activity to degrade the transcript of the gene encoding the polypeptide having phosphoenolpyruvate carboxylase activity, or a polynucleotide that suppresses the translation of the transcript into protein. The same methods as those used to suppress the function of a gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity can be employed for suppressing the function of a gene encoding a polypeptide having pyruvate kinase activity.

[0043] In the present invention, the host bacterium is a Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid. Examples of Corynebacterium bacterium include Corynebacterium glutamicum, Corynebacterium crudilactis, and Corynebacterium suranareeae, with Corynebacterium glutamicum being preferred. The above bacterium may be a wild-type strain, a mutant strain, or an artificially genetically modified organism.

[0044] Corynebacterium bacteria capable of producing 4-hydroxybenzoic acid refer to Corynebacterium bacteria that inherently possess the ability to produce 4-hydroxybenzoic acid and Corynebacterium bacteria to which the ability to produce 4-hydroxybenzoic acid has been conferred. Preferably, these include Corynebacterium bacteria in which the expression of polypeptides having colismyate lyase activity is enhanced or in which a gene encoding polypeptides having colismyate activity has been introduced, and further, in addition to the enhancement of polypeptide expression having colismyate activity or the introduction of a gene encoding polypeptides having colismyate activity, Corynebacterium bacteria in which the expression of polypeptides necessary for the biosynthesis pathway from phosphoenolpyruvic acid to colismyate is enhanced or in which a gene encoding polypeptides necessary for the biosynthesis pathway from phosphoenolpyruvic acid to colismyate is introduced (see Figure 1).

[0045] Therefore, the Corynebacterium bacterial transformant of the present invention is a Corynebacterium bacterial transformant in which the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively, preferably a Corynebacterium bacterial transformant in which the expression of a polypeptide having colismyate lyase activity is enhanced or a gene encoding a polypeptide having colismyate lyase activity is introduced, and more preferably a Corynebacterium bacterial transformant in which the expression of a polypeptide necessary for the biosynthesis pathway from phosphoenolpyruvate to colismyate is further enhanced or a gene encoding a polypeptide necessary for the biosynthesis pathway from phosphoenolpyruvate to colismyate is introduced.

[0046] Polypeptides having colismic acid lyase activity are not particularly limited, and for example, genes encoding polypeptides having colismic acid lyase activity include Pantoea ananatis (nucleotide sequence: SEQ ID NO: 62, amino acid sequence: SEQ ID NO: 63), Providencia rustigianii (nucleotide sequence: SEQ ID NO: 3 or SEQ ID NO: 38, amino acid sequence: SEQ ID NO: 39), Providencia stuartii (nucleotide sequence: SEQ ID NO: 64, amino acid sequence: SEQ ID NO: 65), Providencia sneebia (nucleotide sequence: SEQ ID NO: 66, amino acid sequence: SEQ ID NO: 67), Providencia rettgeri (nucleotide sequence: SEQ ID NO: 68, amino acid sequence: SEQ ID NO: 69), and Providencia alkali faciens (Providencia alcalifaciens) (nucleotide sequence: SEQ ID NO: 70, amino acid sequence: SEQ ID NO: 71), Providencia burhodogranariea (nucleotide sequence: SEQ ID NO: 72, amino acid sequence: SEQ ID NO: 73), Escherichia coli (nucleotide sequence: SEQ ID NO: 74, amino acid sequence: SEQ ID NO: 75), Escherichia fergusonii (nucleotide sequence: SEQ ID NO: 76, amino acid sequence: SEQ ID NO: 77), Pseudoalteromonas piscicida (nucleotide sequence: SEQ ID NO: 78, amino acid sequence: SEQ ID NO: 79), Pseudoalteromonas haloplanktis (nucleotide sequence: SEQ ID NO: 80, amino acid sequence: SEQ ID NO: 81), Cronobacter sakazaki sakazakii) (nucleotide sequence: SEQ ID NO: 82, amino acid sequence: SEQ ID NO: 83), Citrobacter yangae(youngae) (nucleotide sequence: SEQ ID NO: 84, amino acid sequence: SEQ ID NO: 85), Citrobacter koseri (nucleotide sequence: SEQ ID NO: 86, amino acid sequence: SEQ ID NO: 87), Enterobacter aerogenes (nucleotide sequence: SEQ ID NO: 88, amino acid sequence: SEQ ID NO: 89), Enterobacter cloacae (nucleotide sequence: SEQ ID NO: 90, amino acid sequence: SEQ ID NO: 91), Pseudomonas putida (nucleotide sequence: SEQ ID NO: 92, amino acid sequence: SEQ ID NO: 93), Morganella morganii (nucleotide sequence: SEQ ID NO: 94, amino acid sequence: SEQ ID NO: 95), Azotobacter vinelandii (nucleotide sequence: SEQ ID NO: 96, amino acid sequence: SEQ ID NO: 97), Shewanella aptrefaciens Cupriavidus putrefaciens (nucleotide sequence: SEQ ID NO: 98, amino acid sequence: SEQ ID NO: 99), or Cupriavidus taiwanensis.Examples include polypeptides expressed by introducing a polynucleotide, preferably a polynucleotide encoding a polypeptide having colismic acid lyase activity, into a suitable host. This includes a gene derived from Corynebacterium glutamicum (nucleotide sequence: SEQ ID NO: 100, amino acid sequence: SEQ ID NO: 101), or a polynucleotide consisting of a nucleotide sequence having at least 80% identity with the nucleotide sequence of any of these genes. Preferably, the polypeptides expressed by introducing a polynucleotide, preferably a polynucleotide encoding a polypeptide having colismic acid lyase activity, into a suitable host. It has been reported that strains into which genes derived from the above microorganisms have been introduced using Corynebacterium glutamicum as a host have the ability to produce 4-HBA (Patent No. 6327653).

[0047] Preferably, the polypeptide (C) having colismic acid lyase activity is the polypeptide (C1) or (C2) described below. (C1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 39. (C2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 39. Here, the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 39 refers to colismic acid lyase derived from Providencia rustigianii. Colisomemic acid lyase (EC 4.1.3.40) is an enzyme that catalyzes the reaction that produces 4-hydroxybenzoic acid from colismic acid (indicated as "ubiC" in Figure 1).

[0048] In the polypeptide of (C2), the identity with the amino acid sequence shown in SEQ ID NO: 39 is 80% or more, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, still more preferably 97% or more, still more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more. An example of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 39 is an amino acid sequence in which one or more amino acids are deleted, substituted, added, or inserted from the amino acid sequence shown in SEQ ID NO: 39.

[0049] The polypeptide of (C2) is preferably a polypeptide having colismic acid lyase activity. The presence of colismic acid lyase activity in a polypeptide can be confirmed, for example, by adding the polypeptide to a solution containing colismic acid or a salt thereof, lactate dehydrogenase, and NADH, and measuring the decrease in NADH by absorbance.

[0050] A gene encoding a polypeptide having colismyate lyase activity means DNA consisting of a transcription region containing an ORF and a transcriptional regulatory region such as the promoter of the gene. Preferably, the following polynucleotides (c1) or (c2) are used as genes encoding the polypeptide of (C1) or (C2) above. (c1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 3 or 38. (c2) A polynucleotide consisting of a nucleotide sequence having at least 80% identity with the nucleotide sequence shown in SEQ ID NO: 3 or 38. Here, (c1) The polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 38 refers to a gene encoding colismyate derived from Providencia rustidiani. Also, (c1) The polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 3 is a gene encoding colismyate derived from Providencia rustidiani that has been codon-optimized for Corynebacterium glutamicum.

[0051] In the polynucleotide of (c2), the identity with the nucleotide sequence shown in SEQ ID NO: 3 or 38 is 80% or more, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, still more preferably 97% or more, still more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more. An example of a nucleotide sequence having at least 80% identity with the nucleotide sequence shown in SEQ ID NO: 3 or 38 is a nucleotide sequence in which one or more nucleotides are deleted, substituted, added, or inserted from the nucleotide sequence shown in SEQ ID NO: 3 or 38. The polynucleotide of (c2) is preferably a polynucleotide encoding a polypeptide having chorismic acid lyase activity.

[0052] Polypeptides necessary for the biosynthesis pathway from phosphoenolpyruvate to chorismic acid include polypeptides having 2-dehydro-3-deoxyarabinoheptonate aldolase activity (D) or (E), polypeptide having 3-dehydroquinate synthase activity (F), polypeptide having dehydroquinate dehydratase activity (G), polypeptide having shikimate dehydrogenase activity (H), polypeptide having shikimate kinase activity (I), polypeptide having 5-enolate pyruvylshikimate-3-phosphate synthase activity (J), and polypeptide having chorismic acid synthase activity (K). Therefore, enhancing the expression of polypeptides necessary for the biosynthesis pathway from phosphoenolpyruvate to chorismic acid or introducing genes encoding polypeptides necessary for the biosynthesis pathway from phosphoenolpyruvate to chorismic acid can be achieved by enhancing the expression of one or more of these polypeptides or by introducing genes encoding one or more of these polypeptides.

[0053] (D) The polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity (indicated as "aroG" in Figure 1) is preferably (D1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 40 or (D2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 40. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 40 refers to 2-dehydro-3-deoxyarabinoheptonate aldolase derived from Corynebacterium glutamicum. The polypeptide of (D2) is preferably a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity.

[0054] (E) The polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity (indicated as "aroF" in Figure 1) preferably includes (E1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 41 or (E2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 41. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 41 refers to 2-dehydro-3-deoxyarabinoheptonate aldolase derived from Corynebacterium glutamicum. The polypeptide of (E2) is preferably a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity.

[0055] (F) The polypeptide having 3-dehydroquinate synthase activity (indicated as "aroB" in Figure 1) is preferably (F1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 42 or (F2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 42. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 42 refers to 3-dehydroquinate synthase derived from Corynebacterium glutamicum. The polypeptide of (F2) is preferably a polypeptide having 3-dehydroquinate synthase activity.

[0056] (G) The polypeptide having dehydroquinate dehydratase activity (indicated as "aroD" in Figure 1) preferably includes (G1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 43 or (G2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 43. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 43 refers to dehydroquinate dehydratase derived from Corynebacterium glutamicum. The polypeptide of (G2) is preferably a polypeptide having dehydroquinate dehydratase activity.

[0057] (H) The polypeptide having shikimate dehydrogenase activity (indicated as "aroE3" in Figure 1) preferably includes (H1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 44 or (H2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 44. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 44 refers to shikimate dehydrogenase derived from Corynebacterium glutamicum. The polypeptide of (H2) is preferably a polypeptide having shikimate dehydrogenase activity.

[0058] (I) The polypeptide having shikimic acid kinase activity (indicated as "aroK" in Figure 1) is preferably (I1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 45 or (I2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 45. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 45 refers to shikimic acid kinase derived from Corynebacterium glutamicum. The polypeptide of (I2) is preferably a polypeptide having shikimic acid kinase activity.

[0059] (J) The polypeptide having 5-enolate pyruvyl shikimic acid-3-phosphate synthase activity (indicated as "aroA" in Figure 1) preferably includes (J1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 46 or (J2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 46. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 46 refers to 5-enolate pyruvyl shikimic acid-3-phosphate synthase derived from Corynebacterium glutamicum. The polypeptide of (J2) is preferably a polypeptide having 5-enolate pyruvyl shikimic acid-3-phosphate synthase activity.

[0060] (K) The polypeptide having colismic acid synthase activity (indicated as "aroC" in Figure 1) preferably includes (K1) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 47 or (K2) a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 47. The polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 47 refers to colismic acid synthase derived from Corynebacterium glutamicum. The polypeptide of (K2) is preferably a polypeptide having colismic acid synthase activity.

[0061] Examples of amino acid sequences having at least 90% identity with the amino acid sequence shown in any of SEQ ID NOs: 40 to 47 include amino acid sequences having 80% or more identity, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, still more preferably 97% or more, still more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more identity with the amino acid sequence shown in any of SEQ ID NOs: 40 to 47 include amino acid sequences in which one or more amino acids are deleted, substituted, added, or inserted from the amino acid sequence shown in any of SEQ ID NOs: 40 to 47.

[0062] A host Corynebacterium bacterium in which the expression of the polypeptide described above is enhanced or in which the gene encoding the polypeptide has been introduced is, specifically, a Corynebacterium bacterium in which the polynucleotide necessary for the expression of the polypeptide has been introduced in a manner that enables its expression, and the polypeptide may be foreign or naturally present in the bacterium. Examples include a Corynebacterium bacterium in which the polynucleotide has been introduced in a manner that enables its expression, and a Corynebacterium bacterium in which the degree of expression of the polynucleotide has been enhanced. Specifically, examples include a Corynebacterium bacterium into which a vector or DNA fragment containing the polynucleotide and a regulatory region operably linked thereto has been introduced, and a Corynebacterium bacterium in which the regulatory region of the polynucleotide has been replaced with a strongly regulatory region. Here, examples of strongly regulatory regions include, but are not limited to, known high-expression promoters such as the T7 promoter, lac promoter, tac promoter, trp promoter, tu promoter, gap promoter, SPL13 promoter, and the promoter of the cg2875 gene. Furthermore, prokaryotic inducible promoters can be used as strongly regulatory regions. Examples include the vanA promoter, which is induced by the addition of ferulic acid, vanillic acid, or vanillin; the rhcH promoter, which is induced by the addition of resorcinol or 2,4-dihydroxybenzoic acid; the pcaI promoter, which is induced by the addition of 4-hydroxybenzoic acid; the nagI (cg3351) gene promoter, which is induced by the addition of 3-hydroxybenzoic acid; the benA (cg2637) gene promoter (hereinafter abbreviated as Pben), which is induced by the addition of benzoic acid; or the cg2118 gene promoter or the ptsS (cg2925) gene promoter, which are induced by the addition of either fructose or sucrose. However, the examples are not limited to these. Methods for replacing the regulatory regions of polynucleotides present on the genome of host cells with strongly regulatory regions include introducing a DNA fragment containing the strongly regulatory region and the polynucleotide sequence of a selection marker into host cells and selecting cells transformed by homologous or non-homologous recombination.

[0063] Thus, by culturing the produced transformant of the genus Corynebacterium bacterium, evaluating the productivity of 4-hydroxybenzoic acids or salts thereof, and selecting an appropriate transformant, a useful microorganism producing 4-hydroxybenzoic acids or salts thereof can be obtained.

[0064] The method for producing 4-hydroxybenzoic acids or salts thereof of the present invention is carried out by culturing the above-mentioned transformant of the present invention, preferably in the presence of saccharides, and recovering the 4-hydroxybenzoic acids or salts thereof.

[0065] In the present invention, specific examples of "4-hydroxybenzoic acids" include the following general formula (1):

[0066]

[0067] [In the formula, R 1 and R 2 may be the same or different, and each represents a hydrogen atom, a hydroxy group, a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, an amino group or a carboxy group.] 4-hydroxybenzoic acid or a derivative thereof represented by the formula is mentioned.

[0068] In formula (1), R 1 or R 2 Examples of the halogen atom represented by include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, preferably a fluorine atom, a chlorine atom and a bromine atom, and more preferably a fluorine atom. Examples of the alkyl group having 1 to 4 carbon atoms preferably include methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, tert-butyl group and the like, and more preferably methyl group and ethyl group. The alkoxy group having 1 to 4 carbon atoms preferably includes methoxy group, ethoxy group, propoxy group, butoxy group and the like, and more preferably methoxy group.

[0069] In formula (1), R 1 and R 2 may be the same or different, and are more preferably a hydrogen atom, a hydroxy group, a methoxy group, a fluorine atom or a methyl group, and R 1 and R 2It is even more preferable that both are hydrogen atoms. In formula (1), R 1 and R 2 The compound in which both atoms are hydrogen atoms is 4-hydroxybenzoic acid.

[0070] Examples of salts of 4-hydroxybenzoic acids include base addition salts and acid addition salts. Examples of base addition salts include salts with alkali metals such as sodium and potassium, and salts with alkaline earth metals such as calcium and magnesium, while examples of acid addition salts include mineral salts such as hydrochloride, sulfate, nitrate, and phosphate.

[0071] The culture medium for culturing the transformants may be either a natural or synthetic medium, as long as it contains a carbon source, a nitrogen source, inorganic salts, etc., and is capable of efficiently culturing the transformants of Corynebacterium bacteria of the present invention. As a carbon source, sugars or molasses or saccharified liquids containing them can be used, but in addition to sugars, sugar alcohols such as mannitol, sorbitol, xylitol, and glycerin; organic acids such as acetic acid, citric acid, lactic acid, fumaric acid, maleic acid, and gluconic acid; alcohols such as ethanol and propanol; and hydrocarbons such as normal paraffin can also be used. One type of carbon source can be used alone, or two or more types can be used in combination. The concentration of the carbon source in the culture solution is preferably 1 to 20 w / v%, more preferably 2 to 10 w / v%, and even more preferably 2 to 5 w / v%.

[0072] Glucose is preferred as the sugar contained in the culture medium, but monosaccharides such as fructose, mannose, arabinose, xylose, and galactose, as well as sugars that can produce glucose through metabolism, can also be used. Such sugars include oligosaccharides or polysaccharides that have glucose units, and examples include disaccharides such as cellobiose, sucrose, lactose, maltose, trehalose, cellobiose, and xylobiose; and polysaccharides such as dextrin or soluble starch. Molasses can also be used as a raw material containing these sugars, for example. In addition, saccharified liquids containing multiple sugars such as glucose can be used, obtained by saccharifying non-edible agricultural waste such as straw (rice straw, barley straw, wheat straw, rye straw, oat straw, etc.), bagasse, and corn stover, as well as energy crops such as switchgrass, napier grass, and miscanthus, and wood chips and waste paper with saccharifying enzymes. The concentration of sugars in the culture medium is preferably 1 to 20 w / v%, more preferably 2 to 10 w / v%, and even more preferably 2 to 5 w / v%.

[0073] As nitrogen sources, for example, peptone, meat extract, yeast extract, casein hydrolysate, soybean meal alkali extract, alkylamines such as methylamine, nitrogen-containing organic compounds such as amino acids, ammonia or its salts (inorganic or organic ammonium compounds such as ammonium chloride, ammonium sulfate, ammonium nitrate, and ammonium acetate), urea, aqueous ammonia, sodium nitrate, potassium nitrate, etc. can be used.

[0074] Examples of inorganic salts include monopotassium phosphate, dipotassium phosphate, magnesium sulfate, sodium chloride, ferrous nitrate, manganese sulfate, zinc sulfate, cobalt sulfate, and calcium carbonate. Furthermore, vitamins and antifoaming agents may be added as needed. Examples of vitamins include biotin, thiamine (vitamin B1), pyridoxine (vitamin B6), pantothenic acid, inositol, and nicotinic acid.

[0075] Examples of culture media for Corynebacterium bacteria include Medium A [J. Mol. Microbiol. Biotechnol. 7:182-196 (2004)], Medium BT [J. Mol. Microbiol. Biotechnol. 8:91-103 (2004)], Medium CGXII [Patent No. 6322576], etc., and these media should be used with the sugar concentration within the above range.

[0076] Prior to culturing for the production of 4-hydroxybenzoic acids or their salts, it is preferable to culture the transformants in the same medium under aerobic conditions at a temperature of approximately 25 to 38°C for approximately 12 to 48 hours to allow them to grow.

[0077] The culture temperature is preferably 15 to 45°C, and more preferably 25 to 37°C. The culture time is 24 to 168 hours, preferably 24 to 96 hours, more preferably 24 to 72 hours, with stirring or shaking as needed. Antibiotics such as ampicillin or kanamycin may be added to the culture medium as needed during the culture. The culture may be carried out in batch, fed-batch, or continuous manner. Among these, the batch method is preferred. The culture may be carried out under aerobic or reducing conditions, but it is preferable to carry it out under aerobic conditions. When culturing under aerobic conditions, from the viewpoint of the efficiency of 4-hydroxybenzoic acid or its salt production, it is preferable to carry it out under conditions that suppress the excessive growth of the transformants, for example, under conditions where aeration stirring is suppressed and the amount of oxygen supplied is suppressed.

[0078] The method for recovering and purifying 4-hydroxybenzoic acid compounds or their salts from the culture is not particularly limited. That is, it can be carried out by combining well-known methods such as ion exchange resin methods, precipitation methods, crystallization methods, recrystallization methods, concentration methods, and others. For example, 4-hydroxybenzoic acid compounds or their salts can be obtained by removing the microbial cells by centrifugation or the like, then crystallizing and separating them. The 4-hydroxybenzoic acid compounds or their salts accumulated in the culture may be used as is without isolation.

[0079] With respect to the embodiments described above, the present invention further discloses the following embodiments: <1> A transformant of Corynebacterium having the ability to produce 4-hydroxybenzoic acid, wherein the function of the polypeptide having pyruvate kinase activity and the function of the polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively. <2> The transformant according to <1>, wherein the function of the polypeptide having pyruvate kinase activity and the function of the polypeptide having phosphoenolpyruvate carboxylase activity are deleted, respectively. <3> The transformant according to <1> or <2>, wherein the expression of the polypeptide having pyruvate kinase activity and the expression of the polypeptide having phosphoenolpyruvate carboxylase activity are reduced or lost compared to the parent bacterium. <4> The transformant according to <3>, wherein the expression of the polypeptide having pyruvate kinase activity and the expression of the polypeptide having phosphoenolpyruvate carboxylase activity are lost. <5> A transformant according to any one of <1> to <4>, wherein the polypeptide having pyruvate kinase activity is the polypeptide (A1) or (A2) below, and the polypeptide having phosphoenolpyruvate carboxylase activity is the polypeptide (B1) or (B2) below. (A1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 35 (A2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35 (B1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 37 (B2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 <6> A transformant according to <5>, wherein the polypeptide of (A2) is a polypeptide consisting of an amino acid sequence shown in any of SEQ ID NOs: 49, 50, 52, 54, and 55. <7> A transformant according to <5> or <6>, wherein the polypeptide of (A2) is a polypeptide having pyruvate kinase activity. The transformant according to any one of items <5> to <7>, wherein the polypeptide of <8>(B2) is a polypeptide consisting of the amino acid sequence shown in any of sequence numbers 57, 59, and 61.The transformant according to any one of items <5> to <8>, wherein the polypeptide of <9>(B2) is a polypeptide having phosphoenolpyruvate carboxylase activity.

[0080] <10> A transformant according to any one of <1> to <9>, wherein the function of the gene encoding a polypeptide having pyruvate kinase activity and the function of the gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity are each suppressed. <11> A transformant according to <10>, wherein the suppression of gene function is suppression of gene expression or suppression of the activity of the polypeptide encoded by the gene. <12> A transformant according to any one of <1> to <11>, wherein the gene encoding a polypeptide having pyruvate kinase activity and the gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity are each deleted or inactivated. <13> A transformant according to <12>, wherein the gene encoding a polypeptide having pyruvate kinase activity and the gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity are each deleted. <14> A transformant according to any one of <1> to <13>, wherein part or all of the nucleotide sequence of the polynucleotide of (a1) or (a2) below is deleted or inactivated, and part or all of the nucleotide sequence of the polynucleotide of (b1) or (b2) below is deleted or inactivated.(a1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 34 (a2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 34; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35 (b1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 36 (b2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 36; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 <15> The transformant according to <14>, wherein part or all of the nucleotide sequence of the polynucleotide of (a1) or (a2) is deleted, and part or all of the nucleotide sequence of the polynucleotide of (b1) or (b2) is deleted. <16> The transformant according to <14> or <15>, wherein the polynucleotide of (a2) is a polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 34. <17> The transformant according to any one of <14> to <16>, wherein the polynucleotide of (a2) is a polynucleotide encoding a polypeptide having pyruvate kinase activity. <18> The transformant according to any one of <14> to <17>, wherein the polynucleotide of (b2) is a polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 36.A transformant according to any one of claims <14> to <18>, wherein the polynucleotide of <19>(b2) is a polynucleotide encoding a polypeptide having phosphoenolpyruvate carboxylase activity. A transformant according to any one of claims <5> to <19>, wherein at least 90% identity is preferably 95% or more, more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more, and even more preferably 99.5% or more.

[0081] <21> A transformant according to any one of <1> to <20>, wherein the Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having colismyate lyase activity is enhanced or into which a gene encoding a polypeptide having colismyate activity has been introduced. <22> A transformant according to <21>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having colismyate activity has been introduced. <23> The transformant according to <21> or <22>, wherein the gene encoding a polypeptide having colismic acid lyase activity is a polynucleotide consisting of a nucleotide sequence represented by any of SEQ ID NOs: 3, 38, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98 and 100, or a polynucleotide consisting of a nucleotide sequence having at least 80% identity with a nucleotide sequence represented by any of SEQ ID NOs: 3, 38, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98 and 100. <24> The transformant according to <23>, wherein the polynucleotide comprising a nucleotide sequence having at least 80% identity with the nucleotide sequence shown in any of SEQ ID NOs: 3, 38, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, and 100 is a polynucleotide encoding a polypeptide having colismic acid lyase activity. <25> The transformant according to <21> or <22>, wherein the polypeptide having colismic acid lyase activity is the polypeptide of (C1) or (C2) below: (C1) A polypeptide comprising the amino acid sequence shown in SEQ ID NO: 39 (C2) A polypeptide comprising an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 39 <26> The transformant according to <25>, wherein the polypeptide of (C2) is a polypeptide having colismic acid lyase activity. <27> A transformant according to any one of <21> to <26>, wherein the gene encoding a polypeptide having colismic acid lyase activity is (c1) or (c2) as described below.(c1) A polynucleotide comprising the nucleotide sequence shown in SEQ ID NO: 3 or 38. (c2) A polynucleotide comprising a nucleotide sequence having at least 80% identity with the nucleotide sequence shown in SEQ ID NO: 3 or 38. <28> The transformant according to <27>, wherein the polynucleotide of (c2) is a polynucleotide encoding a polypeptide having colismyate lyase activity. <29> The transformant according to any one of <1> to <28>, wherein the Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity is enhanced or into which a gene encoding a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity has been introduced. <30> The transformant according to <29>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity has been introduced. <31> The transformant according to <29> or <30>, wherein the polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity is the polypeptide (D1), (D2), (E1), or (E2) below. (D1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 40 (D2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 40 (E1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 41 (E2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 41 <32> The transformant according to <31>, wherein the polypeptide of (D2) is a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity. <33> The transformant according to <31> or <32>, wherein the polypeptide of (E2) is a polypeptide having 2-dehydro-3-deoxyarabinoheptonate aldolase activity.<34> A transformant according to any one of <1> to <33>, wherein the Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having 3-dehydroquinate synthase activity is enhanced or into which a gene encoding a polypeptide having 3-dehydroquinate synthase activity has been introduced. <35> A transformant according to <34>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having 3-dehydroquinate synthase activity has been introduced. <36> A transformant according to <34> or <35>, wherein the polypeptide having 3-dehydroquinate synthase activity is the polypeptide of (F1) or (F2) below: (F1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 42 (F2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 42 <37> A transformant according to <36>, wherein the polypeptide of (F2) is a polypeptide having 3-dehydroquinate synthase activity. <38> A transformant according to any one of <1> to <37>, wherein the Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having dehydroquinate dehydratase activity is enhanced or into which a gene encoding a polypeptide having dehydroquinate dehydratase activity has been introduced. <39> A transformant according to <38>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having dehydroquinate dehydratase activity has been introduced. <40> A transformant according to <38> or <39>, wherein the polypeptide having dehydroquinate dehydratase activity is the polypeptide of (G1) or (G2) below: (G1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 43 (G2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 43 <41> A transformant according to <40>, wherein the polypeptide of (G2) is a polypeptide having dehydroquinate dehydratase activity.<42> A transformant according to any one of <1> to <41>, wherein the Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having shikimate dehydrogenase activity is enhanced or into which a gene encoding a polypeptide having shikimate dehydrogenase activity has been introduced. <43> A transformant according to <42>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having shikimate dehydrogenase activity has been introduced. <44> A transformant according to <42> or <43>, wherein the polypeptide having shikimate dehydrogenase activity is the polypeptide of (H1) or (H2) below: (H1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 44 (H2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 44 <45> A transformant according to <44>, wherein the polypeptide of (H2) is a polypeptide having shikimate dehydrogenase activity. <46> A transformant according to any one of <1> to <45>, wherein the Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having shikimate kinase activity is enhanced or into which a gene encoding a polypeptide having shikimate kinase activity has been introduced. <47> A transformant according to <46>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having shikimate kinase activity has been introduced. <48> A transformant according to <46> or <47>, wherein the polypeptide having shikimate kinase activity is the polypeptide of (I1) or (I2) below: (I1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 45 (I2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 45 <49> A transformant according to <48>, wherein the polypeptide of (I2) is a polypeptide having shikimate kinase activity.<50> A transformant according to any one of <1> to <49>, wherein the Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having 5-enolate pyruvyl shikimate-3-phosphate synthase activity is enhanced or a gene encoding a polypeptide having 5-enolate pyruvyl shikimate-3-phosphate synthase activity has been introduced. <51> A transformant according to <50>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium in which a gene encoding a polypeptide having 5-enolate pyruvyl shikimate-3-phosphate synthase activity has been introduced. <52> A transformant according to <50> or <51>, wherein the polypeptide having 5-enolate pyruvyl shikimate-3-phosphate synthase activity is the polypeptide of (J1) or (J2) below. (J1) A polypeptide comprising the amino acid sequence shown in Sequence ID No. 46. (J2) A polypeptide comprising an amino acid sequence having at least 80% identity with the amino acid sequence shown in Sequence ID No. 46. <53> The transformant according to <52>, wherein the polypeptide of (J2) is a polypeptide having 5-enolate pyruvyl shikimic acid-3-phosphate synthase activity. <54> The transformant according to any one of <1> to <53>, wherein the Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having colismyate synthase activity is enhanced or into which a gene encoding a polypeptide having colismyate synthase activity has been introduced. <55> The transformant according to <54>, wherein the Corynebacterium bacterium is a Corynebacterium bacterium into which a gene encoding a polypeptide having colismyate synthase activity has been introduced. <56> The transformant according to <54> or <55>, wherein the polypeptide having colismyate synthase activity is the polypeptide of (K1) or (K2) below. (K1) A polypeptide comprising the amino acid sequence shown in SEQ ID NO: 47. (K2) A polypeptide comprising an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 47. <57> The transformant according to <56>, wherein the polypeptide of (K2) is a polypeptide having colismyic acid synthase activity.<58> The transformant according to any one of <23> to <57>, wherein at least 80% identity is preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, still more preferably 97% or more, still more preferably 98% or more, still more preferably 99% or more, and still more preferably 99.5% or more.

[0082] <59> A transformant according to any one of <1> to <58>, wherein the bacterium of the genus Corynebacterium is Corynebacterium glutamicum, Corynebacterium crudilactis, or Corynebacterium suranareae. <60> A transformant according to <59>, wherein the bacterium of the genus Corynebacterium is Corynebacterium glutamicum.

[0083] A method for producing 4-hydroxybenzoic acids or salts thereof, comprising the step of culturing a transformant described in any one of items <61> <1> to <60>. <62> 4-hydroxybenzoic acids are of the following general formula (1):

[0084]

[0085] [In the formula, R 1 and R 2 These may be the same or different, and represent a hydrogen atom, a hydroxyl group, a halogen atom, a C1-C4 alkyl group, a C1-C4 alkoxy group, an amino group, or a carboxyl group.

[0086] The method according to <61>, wherein 4-hydroxybenzoic acid or a derivative thereof is represented by <63>. In general formula (1), R 1 and R 2 The method according to <62>, wherein R may be the same or different, and is a hydrogen atom, a hydroxyl group, a methoxy group, a fluorine atom, or a methyl group. <64> In general formula (1), R 1 and R 2The method according to <62> or <63>, wherein both are hydrogen atoms. <65> The method according to any one of <61> to <64>, wherein the culture is performed in a medium containing sugars as a carbon source. <66> The method according to any one of <61> to <65>, wherein the culture is performed in a batch manner. <67> The method according to any one of <61> to <66>, wherein the culture is performed under conditions of reduced oxygen supply. <68> The method according to any one of <61> to <67>, further comprising the step of recovering 4-hydroxybenzoic acid or a salt thereof from the culture after the culture. <69> The method according to <68>, further comprising the step of removing microbial cells by centrifugation. <70> The method according to <68> or <69>, further comprising the step of crystallizing 4-hydroxybenzoic acid or a salt thereof by crystallization.

[0087] <71> A method for producing a transformed Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively. <72> A method for improving the productivity of 4-hydroxybenzoic acid in Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively.

[0088] The present invention will be described in more detail below based on examples, but the present invention is not limited thereto.

[0089] Example 1 Strain Construction (1) Preparation of a strain into which the ubiC gene, which is linked to the promoter and terminator sequences of the cg2875 gene, is introduced into the cg2088 gene region. 1) Plasmid preparation pECsf_PbenA_nhoA_OPT (PCT / JP2023 / 003089) was amplified by PCR using two types of DNA primers (SEQ ID NOs. 1 and 2) with a template, and the obtained PCR product was treated with DpnI (Takara Bio). The ubiC gene fragment shown in SEQ ID NO. 3, which was synthesized by codon optimization of Corynebacterium glutamicum (Eurofingenomics), was amplified by PCR using two types of DNA primers (SEQ ID NOs. 4 and 5) to obtain a DNA fragment. To the two types of PCR products obtained, each DNA fragment was purified using NucleoSpin Gel and PCR Clean-up (Takara Bio), and plasmid pECsf_PbenA_CL01 was constructed by ligating them using In-Fusion HD Cloning Kit (Takara Bio). pHKPsacB_Δcg2088::Ptu-aroF_P156L (Japanese Patent Application No. 2024-102910) was amplified by PCR using two types of DNA primers (SEQ ID NOs. 6 and 7) as a template, and the obtained PCR product was treated with DpnI (Takara Bio). In addition, the promoter of the cg2875 gene (SEQ ID NO. 8) was amplified by PCR using two types of DNA primers (SEQ ID NOs. 9 and 10) with the genomic DNA of Corynebacterium glutamicum NBRC12168 as a template, and a DNA fragment was obtained. Furthermore, pECsf_PbenA_CL01 was used as a template and amplified by PCR using two types of DNA primers (SEQ ID NOs. 11 and 12). The resulting PCR products were then treated with DpnI (Takara Bio). The three resulting PCR products were purified using NucleoSpin Gel and PCR Clean-up (Takara Bio), and the DNA fragments were ligated using In-Fusion HD Cloning Kit (Takara Bio) to produce plasmid pHKPsacB_Δcg2088::Pcg2875-CL01.

[0090] 2) Recombinant strain construction: Using a transformation method by electroporation (ELEPO21, Neppageen), the plasmid pHKPsacB_Δcg2088::Pcg2875-CL01 described above was introduced into strain KC408 (Japanese Patent Publication No. 2024-003706), and strain KC564sr was obtained by selecting for kanamycin resistance. Strain KC408 is derived from Corynebacterium glutamicum NBRC12168 as the parent strain, and the gene group constituting the pentose phosphate pathway and shikimic acid pathway is enhanced by a high-expression promoter, and the endogenous 4-hydroxybenzoic acid 3-hydroxylase gene (cg1226) is disrupted. Analysis of the KC564sr strain using PCR (KOD One® PCR Master Mix -Blue- (TOYOBO)) with primers SEQ ID NOs. 13 and 14 yielded the expected results, confirming that the KC564sr strain is a once-cross-reacting homologous recombinant with plasmid pHKPsacB_Δcg2088::Pcg2875-CL01 introduced. The KC564sr strain was cultured for 24 hours in 1 mL of LB liquid medium (10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride), and a portion of the culture medium was streaked onto 20% sucrose-containing LB agar to obtain the KC564 strain. Using a PCR method with primers SEQ ID NOs: 14 and 15 (KOD One PCR Master Mix -Blue- (TOYOBO)), it was confirmed that strain KC564 is a double-crossover homologous recombinant in which the ubiC gene, linked to the promoter of the cg2875 gene, is introduced into the cg2088 gene region, as expected.

[0091] (2) Preparation of strains lacking the cg1787(ppc) gene region 1) Construction of plasmids for deleting the cg1787(ppc) gene region The 5' upstream region of the cg1787 gene region (SEQ ID NO: 16) was amplified by PCR using two types of DNA primers (SEQ ID NOs: 17 and 18), and the 3' region of the cg1787 gene region (SEQ ID NO: 19) was amplified by PCR using two types of DNA primers (SEQ ID NOs: 20 and 21) to obtain DNA fragments. In addition, pHKPsacB1 was used as a template and amplified by PCR using two types of DNA primers (SEQ ID NOs: 22 and 23), and the obtained PCR product was treated with DpnI (Takara Bio). The three obtained PCR products were purified using NucleoSpin Gel and PCR Clean-up (Takara Bio), and the plasmid pHKPsacB_Δppc was constructed by ligating them using In-Fusion HD Cloning Kit (Takara Bio).

[0092] 2) Preparation of a strain lacking the cg1787(ppc) gene region: Using electroporation, the plasmid pHKPsacB_Δppc described above was introduced into the KC564 strain, and the KC648sr strain was obtained by selecting it for kanamycin resistance. Analysis of the KC648sr strain by PCR using primers SEQ ID NOs. 17 and 24 (Sapphire Amp (Takara Bio)) yielded the expected results, confirming that the KC648sr strain is a once-crossover homologous recombinant with the plasmid pHKPsacB_Δppc introduced. The KC648sr strain was cultured for 24 hours in 1 mL of LB liquid medium (10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride), and a portion of the culture medium was streaked on LB agar medium containing 20% ​​sucrose to obtain the KC648 strain. Using a PCR method (Sapphire Amp (Takara Bio)) with primers for sequence numbers 24 and 25, it was confirmed that strain KC648 is a double-crossover homologous recombinant with a deletion in the cg1787 (ppc) gene region, as expected.

[0093] (3) Preparation of strains lacking the cg2291(pyk) gene region 1) Construction of plasmids for deleting the cg2291(pyk) gene region The 5' upstream region of the cg2291 gene region (SEQ ID NO: 26) was amplified by PCR using two types of DNA primers (SEQ ID NOs: 27 and 28), and the 3' region of the cg2291 gene region (SEQ ID NO: 29) was amplified by PCR using two types of DNA primers (SEQ ID NOs: 30 and 31) to obtain DNA fragments. In addition, pHKPsacB1 was used as a template and amplified by PCR using two types of DNA primers (SEQ ID NOs: 22 and 23), and the obtained PCR product was treated with DpnI (Takara Bio). The three obtained PCR products were purified using NucleoSpin Gel and PCR Clean-up (Takara Bio), and the plasmid pHKPsacB_Δpyk was constructed by ligating each DNA fragment using In-Fusion HD Cloning Kit (Takara Bio).

[0094] 2) Preparation of a strain lacking the cg2291(pyk) gene region The plasmid pHKPsacB_Δpyk described above was introduced into the KC564 strain using an electroporation transformation method, and the KC653sr strain was obtained by selecting it for kanamycin resistance. Analysis of the KC653sr strain by PCR using primers SEQ ID NOs. 27 and 32 (Sapphire Amp (Takara Bio)) yielded the expected results, confirming that the KC653sr strain is a once-crossover homologous recombinant with the plasmid pHKPsacB_Δpyk introduced. The KC653sr strain was cultured for 24 hours in 1 mL of LB liquid medium (10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride), and a portion of the culture medium was streaked on LB agar medium containing 20% ​​sucrose to obtain the KC653 strain. Using a PCR method (Sapphire Amp (Takara Bio)) with primers for sequence numbers 32 and 33, it was confirmed that strain KC653 is a double-crossover homologous recombinant with a deletion in the cg2291 (pyk) gene region, as expected.

[0095] (4) Preparation of a strain lacking the cg1787 (ppc) gene and cg2291 (pyk) gene regions. The plasmid pHKPsacB_Δpyk described above was introduced into the KC648 strain using an electroporation transformation method, and the KC655sr strain was obtained by selecting it for kanamycin resistance. When the KC655sr strain was analyzed by PCR using primers SEQ ID NOs. 27 and 32 (Sapphire Amp (Takara Bio)), the expected results were obtained, confirming that the KC655sr strain is a one-time crossover homologous recombinant into which the plasmid pHKPsacB_Δpyk has been introduced. The KC655sr strain was cultured for 24 hours in 1 mL of LB liquid medium (10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride), and a portion of the culture medium was streaked onto LB agar medium containing 20% ​​sucrose to obtain the KC655 strain. PCR using primers for SEQ ID NOs. 32 and 33 (Sapphire Amp (Takara Bio)) confirmed that the KC655 strain is a double-crossover homologous recombinant with a deletion in the cg2291 (pyk) gene region, as expected.

[0096] Example 2 Evaluation of 4-hydroxybenzoic acid productivity (1) Culture of transformed strains The transformed strains obtained in Example 1 were streaked onto LB plates and cultured at 30°C for 3 days. The cells grown on the plates were inoculated into 6 mL of CGTG15 medium (Table 2) and cultured with shaking at 30°C and 250 rpm for 24 hours (pre-culture). 60 mL of CGTG15 medium (Urea removed from its components) was placed in a Bio Jr. 8 culture tank (Able Co., Ltd.). 1.2 mL of the pre-culture solution was inoculated and cultured with shaking at 32°C, pH 6.9, 700 rpm, and an aeration rate of 60 mL / min for 24 hours to evaluate the productivity of 4-hydroxybenzoic acid (4-HBA). The culture solution was appropriately diluted with dilute sulfuric acid, the cells were removed by centrifugation, and the supernatant was collected. The concentration of 4-HBA in the supernatant was quantified. The results are shown in Table 1.

[0097]

[0098] In comparison, it was confirmed that the 4-HBA concentration was significantly higher in strain KC655 compared to strains KC564, KC648, and KC653. This indicates that while the deletion of either the ppc gene or the pyk gene individually did not affect 4-HBA production, deletion of both genes improved 4-HBA production.

[0099]

[0100] Furthermore, to evaluate the growth of each strain, the wet cell weight (g / mL) was measured after 24 hours of culture. The results are shown in Table 3. In comparison, strain KC655 showed a wet cell weight equal to or greater than that of the other strains. Therefore, it was confirmed that the double knockout strain of the ppc gene and pyk gene not only improved 4-HBA productivity but could also be cultured without a significant decrease in growth.

[0101]

[0102] <Analysis Conditions> The recovered supernatant was subjected to removal of insoluble matter using an Acroprep 96 filter plate (0.2 μm GHP film, Nippon Pall), and the reaction solution was subjected to HPLC. A Chromaster HPLC system (Hitachi High-Tech Science) was used. For the analysis of 4-HBA, an L-column ODS (4.6 mm I.D. × 150 mm, Chemicals Evaluation and Research Institute) was used, with eluent A being a 0.1% phosphoric acid solution of 0.1 M potassium dihydrogen phosphate and eluent B being 70% methanol. Gradient elution was performed at a flow rate of 1.0 mL / min and a column temperature of 40°C. A UV detector (detection wavelength 280 nm) was used to detect 4-HBA. A concentration calibration curve was created using a standard sample [4-HBA (Tokyo Chemical Industries)], and quantification was performed based on the concentration calibration curve.

Claims

1. A transformed Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid, in which the function of the polypeptide having pyruvate kinase activity and the function of the polypeptide having phosphoenolpyruvate carboxylase activity are suppressed or deleted, respectively.

2. The transformant according to claim 1, wherein the polypeptide having pyruvate kinase activity is the polypeptide of (A1) or (A2) below, and the polypeptide having phosphoenolpyruvate carboxylase activity is the polypeptide of (B1) or (B2) below. (A1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 35 (A2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35 (B1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 37 (B2) A polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 3. The transformant according to claim 2, wherein polypeptide (A2) is a polypeptide having pyruvate kinase activity, and polypeptide (B2) is a polypeptide having phosphoenolpyruvate carboxylase activity.

4. A transformant according to any one of claims 1 to 3, wherein the gene encoding a polypeptide having pyruvate kinase activity and the gene encoding a polypeptide having phosphoenolpyruvate carboxylase activity are each deleted or inactivated.

5. A transformant according to any one of claims 1 to 4, wherein part or all of the nucleotide sequence of the polynucleotide (a1) or (a2) below is deleted or inactivated, and part or all of the nucleotide sequence of the polynucleotide (b1) or (b2) below is deleted or inactivated. (a1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 34 (a2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 34; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 48, 51, and 53, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 35 (b1) A polynucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 36 (b2) A polynucleotide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in SEQ ID NO: 36; a polynucleotide consisting of a nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60; or a polynucleotide encoding a polypeptide consisting of a nucleotide sequence having at least 90% identity with the nucleotide sequence shown in any of SEQ ID NOs: 56, 58, and 60, and an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 37 6. The transformant according to claim 5, wherein the polynucleotide of (a2) is a polynucleotide encoding a polypeptide having pyruvate kinase activity, and the polynucleotide of (b2) is a polynucleotide encoding a polypeptide having phosphoenolpyruvate carboxylase activity.

7. The transformant according to any one of claims 1 to 6, wherein the Corynebacterium bacterium having the ability to produce 4-hydroxybenzoic acid is a Corynebacterium bacterium in which the expression of a polypeptide having colismyate lyase activity is enhanced or into which a gene encoding a polypeptide having colismyate lyase activity has been introduced.

8. The transformant according to claim 7, wherein the polypeptide having colismic acid lyase activity is the polypeptide of (C1) or (C2) below: (C1) A polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 39 (C2) A polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 39 9. The transformant according to claim 8, wherein the polypeptide of (C2) is a polypeptide having colismic acid lyase activity.

10. A method for producing 4-hydroxybenzoic acids or salts thereof, comprising the step of culturing a transformant according to any one of claims 1 to 9.

11. 4-hydroxybenzoic acids have the following general formula (1): [In the formula, R 1 and R 2 The method according to claim 10, wherein the elements are the same or different, and represent a hydrogen atom, a hydroxyl group, a halogen atom, a C1-C4 alkyl group, a C1-C4 alkoxy group, an amino group, or a carboxyl group.

12. The method according to claim 10 or 11, wherein the organism is cultured in a culture medium containing sugars as a carbon source.

13. The method according to any one of claims 10 to 12, further comprising the step of recovering 4-hydroxybenzoic acids or salts thereof from the culture after the culture.

14. A method for producing a transformed Corynebacterium bacterium, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively, in a Corynebacterium bacterium capable of producing 4-hydroxybenzoic acid.

15. A method for improving the productivity of 4-hydroxybenzoic acid in Corynebacterium bacteria having the ability to produce 4-hydroxybenzoic acid, comprising the step of suppressing or deleting the function of a polypeptide having pyruvate kinase activity and the function of a polypeptide having phosphoenolpyruvate carboxylase activity, respectively.